Claritev Corporation (CTEV) Stock Analysis & Winston Score
Claritev Corporation is a healthcare technology company that helps health insurers and other payers manage medical costs. It provides software and data analytics tools that review medical claims — the bills that doctors and hospitals send to insurance companies — to check for errors, flag overcharges, and help negotiate lower payments. The company serves commercial health plans, government programs like Medicaid, and self-insured employers across the United States. Claritev earns revenue primarily by charging fees based on the volume of claims it processes and the savings it generates for clients, giving it a transaction-based revenue model. It operates mainly in the U.S. and competes in a fragmented market where switching costs and proprietary data networks provide some stickiness with existing clients. With a low operating margin of around 4% and a very low return on invested capital, the key risk is that heavy debt loads from prior acquisitions could limit the company's ability to invest in growth or weather a downturn in healthcare spending.
Winston Score: 21/100 — Weak
Weak fundamentals across most pillars.
- Quality: Weak (7/30)
- Growth: Weak (3/20)
- Cash Flow: Weak (0/10)
- Stability: Weak (0/10)
- Valuation: Data not available (0/10)
- Ownership: Good (10/15)

